On 2 April 2025, the GCP team from the Therapeutic Goods Administration (TGA) and Dr. Tanya Symons, an internationally recognised GCP expert, presented this insightful 90-minute webinar on the latest updates to ICH GCP.
This webinar:
- Set expectations regarding the TGA’s process of adopting the updated guidelines, including sector consultation and estimated timelines.
- Gave an overview of the critical changes to ICH GCP E6 R3.
- Demystified new concepts, such as Quality by Design.
- Discussed practical guidance on implementing a flexible and efficient approach to GCP.
- Provided ample Q&A time to address participants’ questions.
This session was designed for anyone seeking to understand the updated ICH-GCP E6 R3 guidelines. The revisions in R3 will impact all professionals working in the clinical research industry.
Please note – This presentation is no longer available for public viewing but Dr Symons will be presenting at the 2025 Clinical Trials and Registries Symposium in November.